Crinetics amends bylaws to adopt universal proxy rules and enhance stockholder proposal disclosures

Crinetics Pharmaceuticals, Inc.

Amended bylaws to comply with SEC universal proxy rules, requiring compliance with Rule 14a-19 for soliciting proxies.
Enhanced procedural and disclosure requirements for stockholder nominations and proposals, including additional background info.
Requires stockholder solicitors to use a proxy card color other than white.
Amendments effective December 6, 2023; include technical and clarifying changes.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Crinetics Pharmaceuticals, Inc.: Amended bylaws to address universal proxy rules, enhance stockholder nomination and proposal disclosure requirements, and require a non-white proxy card color for stockholders soliciting proxies (effective 2023-12-06).

Change: bylaw amendment
Effective: 2023-12-06

Exact text from the filing

On December 6, 2023, the Board of Directors (the “Board”) of Crinetics Pharmaceuticals, Inc. (the “Company”) adopted amendments to the Company’s amended and restated bylaws (as amended, the “Amended and Restated Bylaws”), which became effective the same day.

View on SEC.gov

13 governance changes filed in the last 30 days. Browse all governance changes →

Crinetics Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-069747

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.